Clinical Trials on Pneumococcal Infections in United Kingdom

Total 20200 results

University of Oxford

Completed

A Phase I Study to Assess the Safety and Immunogenicity of Tuberculosis (TB) Vaccine Candidates FP85A and MVA85A

Tuberculosis

United Kingdom
Barts & The London NHS Trust
NHS Research and Development

Unknown

Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis?

Tuberculosis

United Kingdom
Pfizer

Completed

A Study to Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult Participants

Respiratory Syncytial Virus Infections

United Kingdom
Hvivo
Pfizer

Completed

Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults

Respiratory Syncytial Virus Infections

United Kingdom
University of Oxford

Completed

RSV Observational Study 2

Respiratory Syncytial Virus Infections

United Kingdom
Alios Biopharma Inc.

Completed

A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176

Respiratory Syncytial Virus Infections

United Kingdom
University of Edinburgh
NHS Lothian

Completed

Virtual Observed Therapy for Patients With Tuberculosis

Tuberculosis

United Kingdom
Gilead Sciences

Completed

Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) (Challenge)

Respiratory Syncytial Virus Infections

United Kingdom
St George's Healthcare NHS Trust

Unknown

Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in Sputum (MDRTB01)

Tuberculosis

United Kingdom
University of Oxford

Completed

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal Route

Tuberculosis

United Kingdom
Imperial College London
Chelsea and Westminster NHS Foundation Trust; National Heart and Lung Institute and other collaborators

Completed

Defining the Intestinal Microbiota in Premature Neonates

Necrotizing Enterocolitis | Premature Intestinal Microbiota | Late Onset Bloodstream Infection

United Kingdom
NEAT ID Foundation
Merck Sharp & Dohme LLC

Completed

A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/ (DrEW)

HIV I Infection

France, United Kingdom
Dr Lorna Paul
NHS Greater Glasgow and Clyde

Unknown

WEB-Based Physiotherapy for People With Axial Spondyloarthritis

Ankylosing Spondylitis

United Kingdom
Medtronic Surgical Technologies

Completed

Bipolar Sealer Aquamantys Use in Total Knee Replacement

Inflammation | Hemorrhage | Arthritis | Osteoarthritis | Surgery | Disability | Infection

United Kingdom
Loughborough University
University Hospitals, Leicester

Completed

Exercise Therapy in Patients With Axial Spondyloarthritis (ExTASI)

Arthritis | Axial Spondyloarthritis | Inflammatory Disease

United Kingdom
Novartis Vaccines

Completed

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine

Meningococcal Disease

United Kingdom
Objectif Recherche Vaccins SIDA
Merck Sharp & Dohme LLC; Pfizer; Cytheris SA

Completed

Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients (ERAMUNE-01)

HIV-1 Infection

United Kingdom, France, Italy, Spain
Forest Laboratories

Completed

Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy

Helicobacter Infections

United Kingdom
Helen Reynolds
Liverpool University Hospitals NHS Foundation Trust

Completed

The Effect of Intermittent Rifampicin on Raltegravir (RIFRAL)

HIV | Tuberculosis

United Kingdom
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants

Meningococcal Disease

United Kingdom
Novartis Vaccines

Completed

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine

Meningococcal Disease

United Kingdom
Medical Entomology Centre
PN Lee Statistics and Computing Ltd; Leeds Health Protection Unit; Nelsons

Completed

Neem Lotion With Combing for Lice

Head Lice | Pediculoses

United Kingdom
Cell Medica Ltd
Wellcome Trust; EMAS Pharma; Commitum AB; BioAnaLab

Completed

Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study (CMV-IMPACT)

Cytomegalovirus Infection

United Kingdom
ANRS, Emerging Infectious Diseases
University College London Hospitals; Hospital Clinic of Barcelona; Imperial College... and other collaborators

Completed

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

HIV-1-infection

France, United Kingdom, Switzerland
Imperial College London
Biogen; Invicro

Completed

TSPO PET as a Measure of Post-stroke Brain Inflammation: a Natural History Cohort

Inflammatory Response | Stroke, Ischemic | Stroke, Acute

United Kingdom
University of Liverpool
National Institute for Health Research, United Kingdom

Recruiting

Feasibility Study of Contemporary Diagnostics for Patients With Suspected Hospital-Acquired Pneumonia. (HAP-FAST)

Hospital-acquired Pneumonia

United Kingdom
The Whiteley Clinic

Not yet recruiting

Determining Whether There is a Change in Time Taken to Return to Homeostatic Temperature With Repeated Exposure to a Cold Stressor

Needle Phobia | Injection Fear | Needle Fear

United Kingdom
University of Oxford

Completed

Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal Route

Tuberculosis

United Kingdom
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE)

Pneumococcal Infections

United States, Brazil, Colombia, Dominican Republic, Greece, Italy, Panama
Imperial College Healthcare NHS Trust
Barts & The London NHS Trust; Royal Free Hospital NHS Foundation Trust; University... and other collaborators

Active, not recruiting

TB PCR in BAL and EBUS-TBNA (TRiBE)

Tuberculosis

United Kingdom
Pulmocide Ltd

Completed

A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study

Respiratory Syncytial Virus Infections

United Kingdom
University of Oxford
GlaxoSmithKline; Oxford University Hospitals NHS Trust

Completed

Can we Reduce the Number of Vaccine Injections for Children? (MALTA)

Invasive Meningococcal Disease

United Kingdom
GlaxoSmithKline

Completed

Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects

Herpes Zoster

Germany, United States, United Kingdom
Imperial College London

Unknown

Analysis of Human Knee Joint Fluid Using Metabonomic, Genomic and Tribology Techniques

Osteoarthritis | Rheumatoid Arthritis | Septic Arthritis

United Kingdom
Niso Biomed S.R.L.

Unknown

Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy

Helicobacter Infections

United Kingdom
AstraZeneca

Completed

Complications of UTI in Patients on Dapagliflozin

Severe Complications of Urinary Tract Infections

United Kingdom, United States
University of York
Medical Research Council

Completed

A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol (FLYBITE)

Leishmaniasis, Cutaneous | Insect Bites

United Kingdom
St George's, University of London
Public Health England

Recruiting

Propositive (Protecting Positive People From Meningococcal Infection) Follow-up Study

HIV/AIDS | Meningococcal Disease

United Kingdom
St George's, University of London

Unknown

Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population (ProPositive)

HIV Infections | Hiv | Meningitis, Meningococcal

United Kingdom
Guy's and St Thomas' NHS Foundation Trust

Unknown

Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread

Gram-Negative Bacterial Infections

United Kingdom
Barts & The London NHS Trust
British Lung Foundation

Completed

Trial of Adjunctive Vitamin D in Tuberculosis Treatment

Tuberculosis, Pulmonary

United Kingdom
Queen Mary University of London
LAPresearch UK

Unknown

Dynamic Liver Tests in Liver Disease

Hepatitis B | Hepatitis C

United Kingdom
Janssen Research & Development, LLC

Completed

A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection (INSIGHT)

Hepatitis B

France, United States, Belgium, United Kingdom, Poland, New Zealand, Germany, Italy, Canada
Imperial College London
CW+ Charity

Completed

Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus) (REMOTE-COVID)

Coronavirus

United Kingdom
University College, London
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

CMV Glycoprotein B Vaccine in Allograft Recipients

Cytomegalovirus Infections

United Kingdom
Ridgeback Biotherapeutics, LP

Completed

COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers

Coronavirus

United Kingdom
Bionor Immuno AS

Completed

Re-boosting of HIV-1 Infected Subjects With Vacc-4x (Re-boost)

HIV-1 Infection

United States, Spain, Germany, Italy, United Kingdom
AventaMed DAC

Unknown

Clinical Study of the Solo Tympanostomy Tube Device

Otitis Media | Ear Infection

United Kingdom, Italy
UMC Utrecht
Janssen Research & Development, LLC; Innovative Medicines Initiative

Completed

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli-2 (EXPECT-2) (EXPECT-2)

E. Coli Infection

United States, Italy, United Kingdom, Canada, France, Germany, Japan, Spain
University of Oxford

Completed

A Study of Intranasal ChAdOx1 nCOV-19

Coronavirus

United Kingdom

Clinical Trials on Pneumococcal Infections in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations